Ranipets Oral

H₂-Receptor Antagonist – Acid Suppressant

Product Description:
Ranipets Oral is a veterinarian-recommended treatment containing Ranitidine Hydrochloride, formulated to reduce stomach acid secretion and support the management of a wide range of gastrointestinal disorders in companion and large animals. It provides targeted relief for acid-related discomfort and promotes mucosal healing.

Key Benefits:
Reduces stomach acid production
Relieves acid reflux symptoms
Supports ulcer healing
Soothes gastric and esophageal lining
Protects against drug-induced gastritis

How It Works:
Ranitidine is an H₂-receptor antagonist that blocks histamine at stomach receptors, effectively reducing gastric acid output. This mechanism helps minimize irritation and supports tissue recovery in the gastrointestinal tract.

Indications for Use:

• Gastritis: Reduces inflammation of the stomach lining

• Gastric and Duodenal Ulcers: Promotes healing by decreasing acid exposure

• Esophagitis: Alleviates esophageal irritation from acid regurgitation

• Gastroesophageal Reflux: Controls reflux by reducing acid secretion

• Drug-Induced Gastritis: Provides gastric protection during NSAID or corticosteroid therapy

Target Species:
Dogs
Cats
Horses

Active Ingredient (per tablet):
Ranitidine Hydrochloride – Strength varies per formulation

Dosage and Administration:

• Route: Oral

• Dosage: Determined by veterinarian based on species, weight, and clinical condition

• Frequency: Usually administered 2–3 times daily

• May be given with or without food

50 mg Buparvaquone.